Jiangxi Nuoran Biotechnology Co., Ltd – Trademark Portfolio
Entity Type: 16
Jiangxi Nuoran Biotechnology Co., Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The portfolio also extends into Class 28 (Toys & Sporting Goods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PENORAN. The owner is based in Nanchang City.
Rm 3-1003, Bldg. 10，Xiaoping Xiaodao Public Rental Housing, Shengzhuang Village, Wangcheng Town, Xinjian District
Nanchang City 330000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Jiangxi Nuoran Biotechnology Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Jiangxi Nuoran Biotechnology Co., Ltd have?
Jiangxi Nuoran Biotechnology Co., Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Jiangxi Nuoran Biotechnology Co., Ltd file in?
Jiangxi Nuoran Biotechnology Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 28 (Toys & Sporting Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Jiangxi Nuoran Biotechnology Co., Ltd's most well-known trademarks?
Jiangxi Nuoran Biotechnology Co., Ltd's registered trademark portfolio includes well-known marks such as PENORAN. These are among 1 currently registered trademark in the portfolio.
What is Jiangxi Nuoran Biotechnology Co., Ltd's trademark registration success rate?
Jiangxi Nuoran Biotechnology Co., Ltd has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.